# Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

> **NCT03591861** · NA · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 2 (actual)

## Conditions studied

- Pediatric Brain Tumor

## Interventions

- **PROCEDURE:** Ketogenic diet
- **DRUG:** BCNU

## Key facts

- **NCT ID:** NCT03591861
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2022-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03591861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03591861, "Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03591861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*